Michael J. Bourque - 04 Mar 2024 Form 4 Insider Report for Inogen Inc (INGN)

Reporting relationship: EVP, CFO & Treasurer
Issuer ticker: INGN
Reported as of: 04 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Mar 2024, 20:46:25 UTC
Prior SEC filing: 15 Nov 2023
Next SEC filing: 04 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Leslyn Cicekli, as Attorney-in-Fact

Key filing fact

Michael J. Bourque filed Form 4 for Inogen Inc (INGN) on 06 Mar 2024.

Key facts

This page summarizes Michael J. Bourque's Form 4 filing for Inogen Inc (INGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Mar 2024, 20:46.

Change

Previous filing in this sequence was filed on 15 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +75,000
Change %
Price: $0.000000
Shares after: 75,000
Date: 04 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F2

Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.